TGF-beta activates the PI3K/Akt/mTOR pathway and leads to increased migratory capacity and invasiveness during Epithelial-mesenchymal transition (EMT) which facilitates tumor progression and metastasis in PDAC. The gene discussed is MTOR; the disease is neoplasm.